Eversheds Ireland plays key role in the takeover of Paladin Labs by Endo Health

Eversheds Ireland has played a key role in the takeover by Endo Health Solutions of Paladin Labs Europe for approximately £1.1bn.

In this transaction, the acquiring entity will be an Irish holding company. The deal is the first Irish inversion with no primary Irish target.

An inversion is a legal transaction whereby one corporation becomes a subsidiary of another headquartered in a foreign jurisdiction and as a result the original corporation becomes subject to the tax laws of the foreign jurisdiction instead.

  • Print

Briefings from Eversheds

View more briefings from Eversheds

Analysis from The Lawyer

View more analysis from The Lawyer

Overview

1 Wood Street
London
EC2V 7WS
UK
http://www.eversheds.com

Turnover (£m): 376.00
No. of lawyers: 1,264
Jurisdiction: UK
No. of offices: 4
No. of qualified lawyers (international): 54

Jobs

View all jobs from this firm